- Home
- XAIR vs IRIX Comparison
XAIR vs IRIX Comparison
Compare XAIR & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XAIR
- IRIX
- Stock Information
- Founded
- XAIR 2011
- IRIX 1989
- Country
- XAIR United States
- IRIX United States
- Employees
- XAIR N/A
- IRIX N/A
- Industry
- XAIR Medical/Dental Instruments
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- XAIR Health Care
- IRIX Health Care
- Exchange
- XAIR Nasdaq
- IRIX Nasdaq
- Market Cap
- XAIR 27.7M
- IRIX 27.5M
- IPO Year
- XAIR N/A
- IRIX 1996
- Fundamental
- Price
- XAIR $0.39
- IRIX $1.64
- Analyst Decision
- XAIR Strong Buy
- IRIX Hold
- Analyst Count
- XAIR 4
- IRIX 1
- Target Price
- XAIR $3.67
- IRIX $2.00
- AVG Volume (30 Days)
- XAIR 1.2M
- IRIX 31.2K
- Earning Date
- XAIR 02-10-2025
- IRIX 03-25-2025
- Dividend Yield
- XAIR N/A
- IRIX N/A
- EPS Growth
- XAIR N/A
- IRIX N/A
- EPS
- XAIR N/A
- IRIX N/A
- Revenue
- XAIR $2,342,000.00
- IRIX $48,431,000.00
- Revenue This Year
- XAIR $230.80
- IRIX N/A
- Revenue Next Year
- XAIR $265.55
- IRIX $5.44
- P/E Ratio
- XAIR N/A
- IRIX N/A
- Revenue Growth
- XAIR 685.91
- IRIX N/A
- 52 Week Low
- XAIR $0.30
- IRIX $1.27
- 52 Week High
- XAIR $2.17
- IRIX $3.65
- Technical
- Relative Strength Index (RSI)
- XAIR 43.51
- IRIX 47.20
- Support Level
- XAIR $0.33
- IRIX $1.61
- Resistance Level
- XAIR $0.40
- IRIX $1.68
- Average True Range (ATR)
- XAIR 0.04
- IRIX 0.05
- MACD
- XAIR -0.00
- IRIX -0.00
- Stochastic Oscillator
- XAIR 26.35
- IRIX 33.33
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.